BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23386289)

  • 1. Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.
    Leiding JW; Marciano BE; Zerbe CS; Deravin SS; Malech HL; Holland SM
    J Clin Immunol; 2013 May; 33(4):725-30. PubMed ID: 23386289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
    Teimourian S; de Boer M; Roos D
    J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of atherosclerosis in chronic granulomatous disease.
    Sibley CT; Estwick T; Zavodni A; Huang CY; Kwan AC; Soule BP; Long Priel DA; Remaley AT; Rudman Spergel AK; Turkbey EB; Kuhns DB; Holland SM; Malech HL; Zarember KA; Bluemke DA; Gallin JI
    Circulation; 2014 Dec; 130(23):2031-9. PubMed ID: 25239440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes.
    Vázquez N; Lehrnbecher T; Chen R; Christensen BL; Gallin JI; Malech H; Holland S; Zhu S; Chanock SJ
    Exp Hematol; 2001 Feb; 29(2):234-43. PubMed ID: 11166463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.
    Falcone EL; Abusleme L; Swamydas M; Lionakis MS; Ding L; Hsu AP; Zelazny AM; Moutsopoulos NM; Kuhns DB; Deming C; Quiñones M; Segre JA; Bryant CE; Holland SM
    Microbiome; 2016 Apr; 4():13. PubMed ID: 27044504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant.
    Yu L; Cross AR; Zhen L; Dinauer MC
    Blood; 1999 Oct; 94(7):2497-504. PubMed ID: 10498623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
    Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
    Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Granulomatous Disease: a Comprehensive Review.
    Yu HH; Yang YH; Chiang BL
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):101-113. PubMed ID: 32524254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologically important mutations: X-linked chronic granulomatous disease (third update).
    Roos D; Kuhns DB; Maddalena A; Roesler J; Lopez JA; Ariga T; Avcin T; de Boer M; Bustamante J; Condino-Neto A; Di Matteo G; He J; Hill HR; Holland SM; Kannengiesser C; Köker MY; Kondratenko I; van Leeuwen K; Malech HL; Marodi L; Nunoi H; Stasia MJ; Ventura AM; Witwer CT; Wolach B; Gallin JI
    Blood Cells Mol Dis; 2010 Oct; 45(3):246-65. PubMed ID: 20729109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral gene therapy rescues p47
    Schejtman A; Aragão-Filho WC; Clare S; Zinicola M; Weisser M; Burns SO; Booth C; Gaspar HB; Thomas DC; Condino-Neto A; Thrasher AJ; Santilli G
    Gene Ther; 2020 Sep; 27(9):459-469. PubMed ID: 32533104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a large cohort of patients with Chronic Granulomatous Disease and identification of novel CYBB mutations: an Italian multicenter study.
    Di Matteo G; Giordani L; Finocchi A; Ventura A; Chiriaco M; Blancato J; Sinibaldi C; Plebani A; Soresina A; Pignata C; Dellepiane RM; Trizzino A; Cossu F; Rondelli R; Rossi P; De Mattia D; Martire B;
    Mol Immunol; 2009 Jun; 46(10):1935-41. PubMed ID: 19410294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
    Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
    Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kuhns DB; Hsu AP; Sun D; Lau K; Fink D; Griffith P; Huang DW; Priel DAL; Mendez L; Kreuzburg S; Zerbe CS; De Ravin SS; Malech HL; Holland SM; Wu X; Gallin JI
    Blood Adv; 2019 Jan; 3(2):136-147. PubMed ID: 30651282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).
    Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Wolach O; Grisaru-Soen G; Broides A; Etzioni A; Somech R; Roos D
    J Clin Immunol; 2018 Feb; 38(2):193-203. PubMed ID: 29411231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.